StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
ADMA Biologics, Inc.
NasdaqGM:ADMA
Sector
Location
Market Cap
USD 4.42 B
Share Price
USD 18.51
Avg Daily Volume
3,567,826
Change (1 day)
0.22%
Change (1 year)
50.37%
Change (YTD)
7.93%
ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2024: USD 20.22 M
ADMA Biologics, Inc. Accounts Payable is USD 20.22 M for the year ending December 31, 2024, a 29.11% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2023 was USD 15.66 M, a 18.38% change year over year.
-
ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2022 was USD 13.23 M, a 6.43% change year over year.
-
ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2021 was USD 12.43 M, a 12.24% change year over year.
-
ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2020 was USD 11.07 M, a 20.70% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Lonza Group AG
USD 707.88
LONN.SW
-5.04
-0.71%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Hansoh Pharmaceutical Group Company Limited
USD 4.01
3692.HK
-0.05
-1.25%
Summit Therapeutics Inc.
USD 25.00
SMMT
-0.88
-3.40%
Insmed Incorporated
USD 98.18
INSM
+1.52
1.57%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Lonza Group AG
USD 707.88
LONN.SW
-5.04
-0.71%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Hansoh Pharmaceutical Group Company Limited
USD 4.01
3692.HK
-0.05
-1.25%
Summit Therapeutics Inc.
USD 25.00
SMMT
-0.88
-3.40%
Insmed Incorporated
USD 98.18
INSM
+1.52
1.57%